A key protein, LRG1, was identified as the early cause of diabetic eye damage, and blocking it may stop the disease before ...

November is observed as Diabetic Eye Disease Awareness Month, a month dedicated to educating people about the serious eye ...

Diabetes is a systemic disease, which means it affects many organs, including the heart, blood vessels, nerves, kidneys and ...

A long-time supporter of the St John Eye Van, UD Trucks has been formally recognised for its support of the vital regional ...

The FDA has approved Eylea HD (aflibercept) 8 mg to treat patients with macular edema following retinal vein occlusion (RVO) with dosing of up to every 8 weeks after an initial monthly dosing period.

FDA approves Regeneron's Eylea HD for retinal vein occlusion, adding extended dosing options and greater flexibility across ...

Sun Pharma has launched an eye-opening awareness push about a common—and commonly overlooked—complication of diabetes. | Sun Pharma has launched an eye-opening awareness push about a common—and ...

First and only FDA-approved treatment for RVO indicated for up to every 8-week dosing after an initial monthly dosing period Monthly dosing ...

Diabetic eye damage can begin early, even before diagnosis, silently threatening vision. Early screenings and lifestyle ...

VISION 2020: The Right to Sight – India has released the revised National Guidelines for the Management of Diabetic ...

India’s fight against blindness has come a long way. Decades of public health initiatives have helped eliminate several major ...

India has introduced revised national guidelines aimed at reducing blindness caused by diabetic retinopathy, a complication of diabetes affecting millions of Indians.